StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Regenerative Medical Technology's total debt was $2.00M at Jun 30, 2026. For fiscal 2025 it was $2.00M, up 0.0% from the year before. The highest annual figure on record is $11.80M in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.00M0.0%
FY2024Dec 31, 2024$2.00M+5610.5%
FY2023Dec 31, 2023$35.02K+349.0%
FY2022Dec 31, 2022$7.80K-99.9%
FY2021Dec 31, 2021$11.80M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.00M-27.5%
Q1 FY2026Mar 31, 2026$2.00M0.0%
Q4 FY2025Dec 31, 2025$2.00M0.0%
Q3 FY2025Sep 30, 2025$16.94M+42279.7%
Q2 FY2025Jun 30, 2025$2.76M+7772.0%
Q1 FY2025Mar 31, 2025$2.00M+25541.0%
Q4 FY2024Dec 31, 2024$2.00M+25541.0%
Q2 FY2024Jun 30, 2024$39.98K-99.5%
Q4 FY2023Dec 31, 2023$35.02K+349.0%
Q3 FY2023Sep 30, 2023$7.80K-99.9%
Q2 FY2023Jun 30, 2023$7.80K-99.9%
Q1 FY2023Mar 31, 2023$8.76M-25.8%
Q4 FY2022Dec 31, 2022$7.80K–
Q3 FY2022Sep 30, 2022$13.10M–
Q2 FY2022Jun 30, 2022$12.67M–
Q4 FY2021Dec 31, 2021$11.80M–

More Regenerative Medical Technology figures

See a number that looks wrong?